Top 4 NASDAQ Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Below are the top biotechnology stocks on the NASDAQ in terms of PEG ratio.

Aratana Therapeutics (NASDAQ: PETX) has a PEG ratio of 0.30. Aratana Therapeutics' trailing-twelve-month revenue is $0.30 million.

Enzymotec (NASDAQ: ENZY) has a PEG ratio of 0.36. Enzymotec's trailing-twelve-month profit margin is 13.90%.

PDL BioPharma (NASDAQ: PDLI) has a PEG ratio of 0.39. PDL BioPharma's trailing-twelve-month EPS is $1.78.

Questcor Pharmaceuticals (NASDAQ: QCOR) has a PEG ratio of 0.61. Questcor's trailing-twelve-month ROE is 86.50%.